Elucidating the Potential of siRNA Approaches for MASH: The Promise of MITO1041
Time: 11:15 am
day: Conference Day 2 Track 1 AM
Details:
- siRNA therapies can modulate targets that were previously considered un-druggable by conventional small molecule or large molecule approaches
- A GalNAc-SiRNA therapeutic approach is a novel modality to specifically target a single gene in the liver without impact on non-hepatic tissues, leading to a good safety profile
